|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
15.500 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 2.175% | 3.730% | 5.347% | 4.587% | 4.533% |
| ROAE (%) | 5.320% | 8.933% | 12.431% | 10.652% | 11.118% |
| Return on Capital Employed (%) | 3.011% | 5.063% | 7.397% | 6.234% | 5.665% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 47.646% | 47.115% | 47.947% | 54.469% | 59.339% |
| EBITDA Margin (%) | 12.742% | 13.519% | 17.473% | 18.257% | 19.384% |
| Pre-tax Profit Margin (%) | 7.944% | 10.455% | 15.548% | 15.508% | 15.942% |
| Net Profit Margin (%) | 5.815% | 8.530% | 12.167% | 12.143% | 11.700% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.001 X | 1.059 X | 1.038 X | 1.009 X | 1.170 X |
| Quick Ratio (X) | 0.778 X | 0.853 X | 0.851 X | 0.801 X | 0.944 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 50.121% | 49.532% | 48.179% | 45.082% | 48.533% |
| Total Debt / Total Assets (%) | 30.845% | 28.064% | 27.157% | 28.861% | 28.517% |
| Net Debt / Total Assets (%) | 18.773% | 12.901% | 16.093% | 16.949% | 15.984% |
| Total Debt / Shareholders' Funds (%) | 76.650% | 67.502% | 64.702% | 65.341% | 68.144% |
| Long Term Debt / Shareholders' Funds (%) | 34.076% | 28.844% | 24.777% | 24.644% | 40.800% |
| Net Debt / Shareholders' Funds (%) | 46.650% | 31.031% | 38.341% | 38.373% | 38.195% |
| Net Cash / (Debt) ($) | (21.294B) | (13.818B) | (15.006B) | (14.174B) | (12.158B) |
| Net Cash / (Debt) per share ($) | (7.968) | (5.171) | (5.855) | (5.531) | (4.744) |
| Total Debt / Capital Employed (%) | 43.914% | 40.723% | 39.611% | 41.078% | 36.997% |
| Interest Coverage Ratio (X) | 3.473 X | 5.753 X | 8.346 X | 6.310 X | 5.211 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 121.864 Day | 97.316 Day | 95.945 Day | 120.971 Day | 114.273 Day |
| Receivables Turnover (Day) | 67.610 Day | 56.897 Day | 50.964 Day | 56.963 Day | 57.496 Day |
| Payables Turnover (Day) | 55.056 Day | 47.270 Day | 39.223 Day | 34.405 Day | 30.411 Day |
| Remarks: | Real time quote last updated: 11/11/2024 08:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,224,799 |
| %Change | -31.332% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 17.561 |